EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role of NOTCH3 in CADASIL pathogenesis: insights into novel therapies

Favour Felix-Ilemhenbhio, Klaudia Kocsy, Mimoun Azzouz, Arshad Majid

Brain Research · 2025

DOI: 10.1016/j.brainres.2025.149754 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain Research, 2025. Verfasst von Favour Felix-Ilemhenbhio und 3 weiteren Autor:innen. Beteiligte Einrichtung: The University Sheffield, Sheffield Institute for Translational Neuroscience, United Kingdom. Hauptthemen laut MEDLINE: CADASIL, Receptor, Notch3. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 175 Literaturangaben. Gefördert von: National Institute for Health and Care Research, NIHR Sheffield Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a monogenetic hereditary small-vessel disorder characterised by recurrent subcortical ischemic strokes, cognitive deterioration, and other neurological symptoms. Single nucleotide mutations within the NOTCH3 gene can impair NOTCH3 processing and/or signalling, resulting in the accumulation of granular osmiophilic material (GOM) in blood vessel walls, and consequently CADASIL. Despite its significant clinical impact, there is currently no definitive treatment for CADASIL. This review provides a comprehensive analysis of the pathophysiological mechanisms underlying CADASIL, focusing on NOTCH3 mutations and their effects on protein processing and signalling. The review proposes a hypothesis that explains how NOTCH3 mutations may alter the signalling process and result in GOMs. Additionally, the review explores published therapy strategies aimed at restoring normal NOTCH3 function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CADASILReceptor, Notch3HumansMutationAnimalsSignal Transduction

Stichwörter der Autor:innen

CADASILCerebrovascular diseaseGene therapyNOTCH3StrokeVascular smooth muscle cells (VSMCs)

Substanzen

Receptor, Notch3NOTCH3 protein, human

Autor:innen und Institutionen

  • The University Sheffield, Sheffield Institute for Translational Neuroscience, United Kingdom.
  • The University Sheffield, Sheffield Institute for Translational Neuroscience, United Kingdom. Electronic address: arshad.majid@sheffield.ac.uk.

Förderung

  • National Institute for Health and Care Research
  • NIHR Sheffield Biomedical Research Centre

Zitieren

APA

Felix-Ilemhenbhio, F., Kocsy, K., Azzouz, M., & Majid, A. (2025). The role of NOTCH3 in CADASIL pathogenesis: insights into novel therapies. Brain Research. https://doi.org/10.1016/j.brainres.2025.149754

Vancouver

Felix-Ilemhenbhio F, Kocsy K, Azzouz M, Majid A. The role of NOTCH3 in CADASIL pathogenesis: insights into novel therapies. Brain Research. 2025. doi:10.1016/j.brainres.2025.149754

BibTeX
@article{FelixIlemhenbhio2025,
  author = {Felix-Ilemhenbhio, Favour and Kocsy, Klaudia and Azzouz, Mimoun and Majid, Arshad},
  title = {The role of NOTCH3 in CADASIL pathogenesis: insights into novel therapies},
  journal = {Brain Research},
  year = {2025},
  doi = {10.1016/j.brainres.2025.149754}
}
Kostenlos starten →